Larimar Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. 0.16%243.691.5%$880.53m
MRNAModerna, Inc. 4.59%149.400.0%$807.72m
VRTXVertex Pharmaceuticals, Inc. 0.73%283.851.9%$483.34m
GILDGilead Sciences, Inc. -0.01%61.811.0%$475.40m
REGNRegeneron Pharmaceuticals, Inc. -0.04%590.892.6%$471.47m
NVAXNovavax, Inc. 9.08%56.1075.7%$434.71m
ILMNIllumina, Inc. 2.47%188.923.3%$344.17m
SNSSSunesis Pharmaceuticals, Inc. -5.41%3.670.7%$256.55m
BIIBBiogen, Inc. 1.60%207.211.8%$241.89m
BNTXBioNTech SE 4.45%155.730.0%$195.48m
CRSPCRISPR Therapeutics AG 2.84%62.500.6%$164.65m
BMRNBioMarin Pharmaceutical, Inc. 1.11%83.794.2%$117.47m
EXASEXACT Sciences Corp. 3.07%40.6017.7%$93.72m
IOVAIovance Biotherapeutics, Inc. 2.90%11.360.0%$90.66m
TECHBio-Techne Corp. 0.56%348.584.5%$90.12m

Company Profile

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.